At the molecular level, GBM is characterized by the absence of isocitrate dehydrogenase (IDH) gene mutations (glioblastoma, IDH-wild type) and specific genetic alterations in the TERT promoter, chromosomes 7/10, and the EGFR gene. Here, EGFR is linked to glioblastoma.